A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation.

Platelet rich fibrin (PRF) has been utilized clinically as a platelet concentrate capable of stimulating tissue regeneration. Interestingly, several protocols have been proposed with little data obtained regarding the final cell counts following centrifugation. The aim of the present study was to compare different commercially available centrifuges and their respective protocols utilizing a novel method to quantify cells. One millimeter blood layers following centrifugation were sequentially pipetted from the upper layer downward until all 10 mL were harvested in sequential samples. Thereafter, each sample was sent for CBC analysis to accurately quantify precisely cell numbers within each separate blood layer following centrifugation. The results from this study revealed that L-PRF protocols (2700 rpm × 12 min) produced a clot with the majority of platelets and leukocytes concentrated within the buffy coat with relatively no cells found within the first 4 mL of L-PRF. Slower centrifugation protocols produced using the A-PRF protocols (1300 rpm × 8 min) produced a more evenly distributed number of platelets throughout PRF. Injectable-PRF (i-PRF) protocols produced the highest concentration of leukocytes/platelets, however, the total number of leukocytes and platelets were significantly lower owing to the decreased total volume collected. Horizontal centrifugation produced a significant increase in both the number and concentration of platelets and leukocytes (up to 3.5× higher for either solid/liquid PRF). When compared to either fixed or angled centrifuge (InstraSpin, Process for PRF). In conclusion, the present study revealed a novel/accurate method to quantify cells following PRF protocols. Furthermore, PRF produced via horizontal centrifugation accumulated a higher number and concentration of platelets/leukocytes when compared to either fixed-angle centrifugation.

[1]  M. Quirynen,et al.  Standardization of relative centrifugal forces in studies related to platelet-rich fibrin. , 2019, Journal of periodontology.

[2]  M. Barbeck,et al.  A low-speed centrifugation concept leads to cell accumulation and vascularization of solid platelet-rich fibrin: an experimental study in vivo , 2019, Platelets.

[3]  S. Ghanaati,et al.  A Proof of the Low Speed Centrifugation Concept in Rodents: New Perspectives for In Vivo Research. , 2018, Tissue engineering. Part C, Methods.

[4]  S. Ghanaati,et al.  Controversies related to scientific report describing g-forces from studies on platelet-rich fibrin: Necessity for standardization of relative centrifugal force values , 2018 .

[5]  J. Granjeiro,et al.  The in vitro release of cytokines and growth factors from fibrin membranes produced through horizontal centrifugation. , 2018, Journal of biomedical materials research. Part A.

[6]  S. Ghanaati,et al.  Use of platelet-rich fibrin in regenerative dentistry: a systematic review , 2017, Clinical Oral Investigations.

[7]  S. Ghanaati,et al.  Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept) , 2017, European Journal of Trauma and Emergency Surgery.

[8]  S. Ghanaati,et al.  Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept , 2017, European Journal of Trauma and Emergency Surgery.

[9]  S. Ghanaati,et al.  Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? , 2017, Clinical Oral Investigations.

[10]  U. Kandalam,et al.  Optimized Platelet‐Rich Fibrin With the Low‐Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response , 2017, Journal of periodontology.

[11]  L. Goldberg,et al.  Autologous Platelet-Rich Plasma for the Treatment of Pattern Hair Loss , 2016, American Journal of Clinical Dermatology.

[12]  Joshua D. Harris,et al.  Efficacy of Intra-articular Platelet-Rich Plasma Injections in Knee Osteoarthritis: A Systematic Review. , 2016, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[13]  R. Miron,et al.  Comparative release of growth factors from PRP, PRF, and advanced-PRF , 2016, Clinical Oral Investigations.

[14]  Xiang-jin Lin,et al.  Efficacy of platelet-rich plasma in arthroscopic repair of full-thickness rotator cuff tears: a meta-analysis. , 2015, Journal of shoulder and elbow surgery.

[15]  S. Ghanaati,et al.  Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. , 2014, The Journal of oral implantology.

[16]  T. Albrektsson,et al.  Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). , 2009, Trends in biotechnology.

[17]  R. Marx.  Platelet-rich plasma: evidence to support its use. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[18]  R. Marx,et al.  Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[19]  S. Simske,et al.  Effect of microgravity, temperature, and concentration on fibrin and collagen assembly. , 1995, Microgravity science and technology.

[20]  D. Roos,et al.  Platelet activation during preparation of platelet concentrates: a comparison of the platelet‐rich plasma and the buffy coat methods , 1990, Transfusion.

[21]  M. Trovati,et al.  Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood. , 1989, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  L. McIntire,et al.  Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties. , 1983, Thrombosis research.

[23]  M. Donati,et al.  Enhanced Affinity for Arachidonic Acid in Platelet-Rich Plasma from Rats with Adriamycin-Induced Nephrotic Syndrome , 1982, Thrombosis and Haemostasis.